Menu
GeneBe

rs121912980

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong

The NM_000031.6(ALAD):c.397G>A(p.Gly133Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,607,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/23 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

ALAD
NM_000031.6 missense, splice_region

Scores

18
1
Splicing: ADA: 0.9999
2

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 7.39
Variant links:
Genes affected
ALAD (HGNC:395): (aminolevulinate dehydratase) The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway; zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.992
PP5
Variant 9-113390798-C-T is Pathogenic according to our data. Variant chr9-113390798-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 16862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ALADNM_000031.6 linkuse as main transcriptc.397G>A p.Gly133Arg missense_variant, splice_region_variant 5/12 ENST00000409155.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ALADENST00000409155.8 linkuse as main transcriptc.397G>A p.Gly133Arg missense_variant, splice_region_variant 5/121 NM_000031.6 P1P13716-1
ALADENST00000464749.5 linkuse as main transcriptn.393G>A non_coding_transcript_exon_variant 3/34
ALADENST00000468504.5 linkuse as main transcriptn.519G>A non_coding_transcript_exon_variant 5/75
ALADENST00000482847.5 linkuse as main transcriptn.670G>A splice_region_variant, non_coding_transcript_exon_variant 5/122

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152110
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000127
AC:
3
AN:
236968
Hom.:
0
AF XY:
0.00000780
AC XY:
1
AN XY:
128124
show subpopulations
Gnomad AFR exome
AF:
0.000131
Gnomad AMR exome
AF:
0.0000308
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000124
AC:
18
AN:
1455788
Hom.:
0
Cov.:
34
AF XY:
0.0000166
AC XY:
12
AN XY:
723760
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000465
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000760
Gnomad4 SAS exome
AF:
0.0000351
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000721
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152110
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74292
show subpopulations
Gnomad4 AFR
AF:
0.000169
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000180
Hom.:
0
Bravo
AF:
0.0000604
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Porphobilinogen synthase deficiency Pathogenic:3
Pathogenic, no assertion criteria providedliterature onlyOMIMJul 01, 1991- -
Likely pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 22, 2023- -
Likely pathogenic, criteria provided, single submitterclinical testingGreenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic CenterNov 14, 2022PS3, PM1, PM3 -
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingInvitaeAug 02, 2021In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). RNA analysis indicates that this variant does not impact mRNA splicing (PMID: 2063868). Experimental studies have shown that this missense change affects ALAD protein function (PMID: 11071662, 11342419, 17236137, 19015748). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 16862). This missense change has been observed in individual(s) with clinical features of δ-aminolevulinic acid dehydratase deficiency porphyria (PMID: 2063868, 11071662). This variant is present in population databases (rs121912980, ExAC 0.02%). This sequence change replaces glycine with arginine at codon 133 of the ALAD protein (p.Gly133Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant also falls at the last nucleotide of exon 5, which is part of the consensus splice site for this exon. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.37
D
BayesDel_noAF
Pathogenic
0.54
Cadd
Pathogenic
35
Dann
Pathogenic
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Pathogenic
0.91
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.45
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.9
H
MutationTaster
Benign
1.0
A;A
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.99
MutPred
0.98
Loss of catalytic residue at L134 (P = 0.0899);
MVP
0.98
MPC
1.3
ClinPred
1.0
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.99
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.97
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121912980; hg19: chr9-116153078; API